scispace - formally typeset
J

Joel A G van Roon

Researcher at Utrecht University

Publications -  94
Citations -  3561

Joel A G van Roon is an academic researcher from Utrecht University. The author has contributed to research in topics: Proinflammatory cytokine & T cell. The author has an hindex of 29, co-authored 84 publications receiving 2843 citations.

Papers
More filters
Journal ArticleDOI

Proinflammatory mediator–induced reversal of CD4+,CD25+ regulatory T cell–mediated suppression in rheumatoid arthritis

TL;DR: The findings suggest that the interaction of CD4+,CD25+ Treg cells with activated monocytes in the joint might lead to diminished suppressive activity of CD 4+,CD 25+ T Reg cells in vivo, thus contributing to the chronic inflammation in RA.
Journal ArticleDOI

Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis.

TL;DR: The important role of T helper cells, macrophages, dendritic cells (DC), and B cells in local tissue destruction in RA has been described extensively and several antiinflammatory mechanisms in response to the proinflammatory activity are activated in the RA joint in an attempt to control the dysregulated (auto)immune reactivity.
Journal ArticleDOI

The Role of Ectopic Germinal Centers in the Immunopathology of Primary Sjögren's Syndrome: A Systematic Review

TL;DR: Patients with GCs are characterized by more severe disease, although the small number of studies and their design hamper generalizability of results, and the strongly increased risk of lymphoma development warrant intensive studies for the role of germinal centers in the immunopathology of pSS.
Journal ArticleDOI

Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study

TL;DR: This multi-biomarker test performed well in the assessment of disease activity in RA patients in the CAMERA study and could be used to complement currently available disease activity measures and improve patient care and outcomes.